Skip to main content

Advertisement

Log in

Very late local recurrence after surgery for prostate cancer unaccompanied by detectable PSA levels

  • Case Report
  • Published:
Prostate Cancer and Prostatic Diseases Submit manuscript

Abstract

The possibility and possible aetiology of local prostate cancer (PC) recurrence despite undetectable prostate-specific antigen (PSA) levels are highlighted. A case of a local recurrence 8.5 years after radical prostatectomy for Gleason 3+4 PC is presented. It demonstrates that PC can recur, even after a prolonged period of time (8.5 years), despite undetectable levels (i.e. <0.02 ng/ml) of PSA. In conclusion, the decision to omit digital rectal examination from the follow-up regimens of men with undetectable PSA levels could be justified. In such exceptional cases, however, PC recurrence would be either missed or would only be diagnosed after a considerable delay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  1. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E . Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909–916.

    Article  CAS  Google Scholar 

  2. Oh J, Colberg JW, Ornstein DK, Johnson ET, Chan D, Virgo KS et al. Current follow up strategies after radical prostatectomy: a survey of American Urological Association Urologists. J Urol 1999; 161: 520–523.

    Article  CAS  Google Scholar 

  3. Pound CR, Christens-Barry OW, Gurganus RT, Partin AW, Walsh PC . Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy. J Urol 1999; 162: 1337–1340.

    Article  CAS  Google Scholar 

  4. Gleason DF . Histologic grading of prostate cancer: a perspective. Hum Pathol 1992; 23: 273–279.

    Article  CAS  Google Scholar 

  5. Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M . The TNM classification of prostate cancer. Prostate Suppl 1992; 4: 129–138.

    Article  CAS  Google Scholar 

  6. Goldrath DE, Messing EM . Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy. J Urol 1989; 142: 1082–1084.

    Article  CAS  Google Scholar 

  7. Oefelein MG, Smith N, Carter M, Dalton D, Schaeffer A . The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies. J Urol 1995; 154: 2128–2131.

    Article  CAS  Google Scholar 

  8. Chaplin BJ, Wildhagen MF, Schroder FH, Kirkels WJ, Bangma CH . Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up. Eur Urol 2005; 48: 906–910.

    Article  Google Scholar 

  9. Leibman BD, Dillioglugil O, Wheeler TM, Scardino PT . Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen level. Cancer 1995; 76: 2530–2534.

    Article  CAS  Google Scholar 

  10. Takayama TK, Krieger JN, True LD, Lange PH . Recurrent prostate cancer despite undetectable prostate specific antigen. J Urol 1992; 148: 1541–1542.

    Article  CAS  Google Scholar 

  11. Stege RH, Tribukait B, Carlstrom KA, Grande M, Pousette AH . Tissue PSA from fine-needle biopsies of prostatic carcinoma as related to serum PSA, clinical stage, cytological grade, and DNA ploidy. Prostate 1999; 38: 183–188.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Roemeling.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roemeling, S., van Leenders, G. & Schröder, F. Very late local recurrence after surgery for prostate cancer unaccompanied by detectable PSA levels. Prostate Cancer Prostatic Dis 9, 192–194 (2006). https://doi.org/10.1038/sj.pcan.4500861

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500861

  • Springer Nature Limited

Keywords

Navigation